# Biozon Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biozon-medical

- Industry: Healthcare
- Headquarters: Hangzhou, China
- Website: www.biozon.com
- Total disclosed funding: $46M
- Latest round: Series C (Mar 3, 2021)
- Investors on record: 8

## About

Based in Hangzhou, China and established in 2015, Biozon Medical is a medical company which focuses on R&D of mass spectrometry technology and provides related application and disease detection service.

## Funding rounds

- Series C, Mar 3, 2021, $46M — CPE Funds Management, Huagai Capital, Sherpa Healthcare Partners
- Series B, Apr 30, 2020 — Zhongguancun Co-Innovative Fund Management
- Series A, May 25, 2018 — Fortune Capital, Everest VC, Kingcaptial-TC, Vinno Capital

## Investors

- Fortune Capital — Series A
- Everest VC (https://capitalatlas.ai/funds/everest-vc) — Series A
- Kingcaptial-TC (https://capitalatlas.ai/funds/kingcaptial-tc) — Series A
- Vinno Capital (https://capitalatlas.ai/funds/vinno-capital) — Series A
- Zhongguancun Co-Innovative Fund Management (https://capitalatlas.ai/funds/zhongguancun-co-innovative-fund-management) — Series B
- CPE Funds Management (https://capitalatlas.ai/funds/cpe-funds-management) — Series C
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series C
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series C